Quarterly Result29 Dec 2025, 03:14 pm
Samrat Pharmachem Ltd. to Approve Q3 Results on February 13, 2026
AI Summary
Samrat Pharmachem Ltd. has announced that its Board of Directors will meet on February 13, 2026, to consider and approve the un-audited financial results for the quarter ended December 31, 2025. The meeting will take place at the company's corporate office in Mumbai.
Key Highlights
- The meeting is scheduled for February 13, 2026.
- The Board will consider and approve the un-audited financial results for Q3 2025-2026.
- The meeting will be held at the company's corporate office in Mumbai.
- The results will be announced on the company's website and in the press after the Board meeting.
Price Impact
More from SAMRATPH